Seeking Alpha
Seeking Alpha Portfolio App for iPad
Finance
(1)

Elias Simpson

View as an RSS Feed
View Elias Simpson's Comments BY TICKER:
Latest  |  Highest rated
  • SunOpta: 2012 Recap And What's The Next Catalyst [View article]
    thanks for the article, i should say.

    just read the IPO deal for Mascoma was cancelled.

    more waiting for that value?
    Apr 5 10:39 PM | Likes Like |Link to Comment
  • SunOpta: 2012 Recap And What's The Next Catalyst [View article]
    Any idea what kind of notice will be given in advance of the sale of OPM? Couldn't one wait to see the deal before investing for this reason?
    Apr 5 10:31 PM | Likes Like |Link to Comment
  • Cooper's Warrants: Free Play On Leveraged Upside [View article]
    so those shares that don't sell at $43 will race to be sold off, driving prices back down, appx. 60% towards where it was before the offer ($36). By these numbers it would drop $4.20, to $38.80.

    is that how the proration factor would effect the price? with a smaller float, would it be reasonable to assume that the effect would be 20% less? so a drop of $3.36 to $39.64?
    Apr 5 02:49 PM | Likes Like |Link to Comment
  • Cooper's Warrants: Free Play On Leveraged Upside [View article]
    Wouldn't a smaller float mitigate a significant drop post-tender?

    I'm ignorant to this, but how would the proration factor effect stock price?

    -Thank you.
    Apr 5 01:35 PM | Likes Like |Link to Comment
  • Will Genworth Financial Triple? [View article]
    Who doesn't love a good old fashioned rate increase?
    Mar 13 06:25 PM | Likes Like |Link to Comment
  • A Closer Look At Keryx Biopharmaceuticals' Phase III Result Announcement [View article]
    heh. mug slinging.
    Feb 19 01:31 AM | Likes Like |Link to Comment
  • Gran Tierra Energy Represents Value For Investors, But There Are Better Value Opportunities In Colombia [View article]
    I'd rather invest in companies that aren't in the process of destroying the rainforests.
    Jan 18 01:34 PM | Likes Like |Link to Comment
  • Why Map Pharmaceuticals Is The Cheapest Biotech Out There [View article]
    Great technical setup, and good timing with the catalyst approaching. An abortive migraine drug would be a lifesaver, but this one seems only moderately effective (relieving about half of patients compared to 30% success for placebo).
    Jan 9 03:21 PM | Likes Like |Link to Comment
  • What Is Keryx Biopharmaceuticals And Why Does It Matter? [View article]
    This is Ron Bentsur of decimated XTL Biopharma...ugly story for investors.
    Jan 9 03:13 PM | Likes Like |Link to Comment
  • Amira Nature Foods Looks To Become A Major Emerging Market Brand [View article]
    Thanks for the article. I once tried some Indian snack food from a world market and I can't say I liked it. Part of it was strictly taste, but some was the obviously "foreign" packaging with an odd bright-forest-green color, hard-to-open metallic wrapping, and only a few awkward words in English. This is just to point out that there are hurdles for non-American companies when trying to penetrate the market here. I will keep an eye out for Amira at Costco. Just looking at the products on google.images, however, they packaging looks pretty silly. The slogan "Good Length" on most of the products doesn't even make sense. Is it talking about the cook time, the length of the grain, good for what type of cooking? Interesting idea, though, for getting in on the basmati rice market.
    Jan 9 02:41 PM | Likes Like |Link to Comment
  • With Osiris Overvalued, NeoStem Is A Better Buy [View article]
    Hopefully all the conference presentations from NBS this month will spur some upward trending with good news.
    Jan 3 09:50 AM | Likes Like |Link to Comment
  • Another Downgrade For Skullcandy And Another Oversized Response [View article]
    According to Fidelity, SKUL still has a .4 PEG ratio, nearly 1/3 the industry average of 1.11.
    Jan 3 09:25 AM | Likes Like |Link to Comment
  • Netflix Gives Reed Hastings Huge Raise: Why? [View article]
    Hi Bill, It's always good to know what the guy on the top is getting. It certainly effects investors, one way or another.
    Dec 31 03:27 PM | 2 Likes Like |Link to Comment
  • Frothy Finance Makes Conn's Inc. An Attractive Short [View article]
    Thanks for your thoughts. There's obviously limited room for growth in financing unless you can keep growing the retail. Considering valuation, I definitely see a case for shorting.
    Dec 31 03:21 PM | 1 Like Like |Link to Comment
  • Hewlett-Packard: Taking A Chance With The Dow's Biggest Loser Of 2012 [View article]
    Very clever introduction. I will investigate some of the downside risks on my own, but thanks for your optimism.
    Dec 25 07:05 PM | Likes Like |Link to Comment
COMMENTS STATS
28 Comments
11 Likes